ENTX
Price:
$1.795
Market Cap:
$65.20M
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Ente...[Read more]
Industry
Biotechnology
IPO Date
2018-06-28
Stock Exchange
NASDAQ
Ticker
ENTX
According to Entera Bio Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 56.40M. This represents a change of 64.45% compared to the average of 34.30M of the last 4 quarters.
The mean historical Enterprise Value of Entera Bio Ltd. over the last ten years is 32.92M. The current 56.40M Enterprise Value has changed 17.04% with respect to the historical average. Over the past ten years (40 quarters), ENTX's Enterprise Value was at its highest in in the June 2021 quarter at 121.25M. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.
Average
32.92M
Median
16.76M
Minimum
6.78M
Maximum
81.56M
Discovering the peaks and valleys of Entera Bio Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 318.67%
Maximum Annual Enterprise Value = 81.56M
Minimum Annual Increase = -82.06%
Minimum Annual Enterprise Value = 6.78M
Year | Enterprise Value | Change |
---|---|---|
2023 | 6.78M | -23.11% |
2022 | 8.81M | -82.06% |
2021 | 49.11M | 318.67% |
2020 | 11.73M | 5.59% |
2019 | 11.11M | -33.72% |
2018 | 16.76M | -63.56% |
2017 | 45.99M | -28.59% |
2016 | 64.40M | -21.04% |
The current Enterprise Value of Entera Bio Ltd. (ENTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
21.56M
5-year avg
17.51M
10-year avg
32.92M
Entera Bio Ltd.’s Enterprise Value is greater than NLS Pharmaceutics AG (11.69M), greater than Vaccinex, Inc. (8.97M), greater than Alterity Therapeutics Limited (2.87M), less than Enochian Biosciences, Inc. (101.51M), less than Immutep Limited (245.67M),
Company | Enterprise Value | Market cap |
---|---|---|
11.69M | $10.53M | |
8.97M | $9.08M | |
2.87M | $10.11M | |
101.51M | $45.38M | |
245.67M | $267.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entera Bio Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Entera Bio Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Entera Bio Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Entera Bio Ltd. (ENTX)?
What is the 3-year average Enterprise Value for Entera Bio Ltd. (ENTX)?
What is the 5-year average Enterprise Value for Entera Bio Ltd. (ENTX)?
How does the current Enterprise Value for Entera Bio Ltd. (ENTX) compare to its historical average?